
home All News open_in_new Full Article
Hong Kong team develops test that detects nasopharyngeal cancer with 97% accuracy

A Hong Kong research team at the Chinese University of Hong Kong developed a new blood screening method that uses sequencing technology to detect cancer-associated Epstein-Barr virus (EBV) DNA, identifying high-risk nasopharyngeal cancer patients with 97% accuracy. The study found individuals with cancer-associated EBV DNA in their blood had an 87-fold increased risk of developing the illness.
today 33 h. ago attach_file Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Science
attach_file
Science
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
ID: 287110546